|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 |
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 3)*
|
Innovex International, Inc. (Name of Issuer) |
Common Stock, par value $0.01 per share (Title of Class of Securities) |
(CUSIP Number) |
Jason Turowsky Amberjack Capital Partners, L.P., 4400 Post Oak Parkway, Suite 2760 Houston, TX, 77002 (281) 605-3900 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) |
08/06/2026 (Date of Event Which Requires Filing of This Statement) |
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
Amberjack Capital Fund II, L.P. | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
WC | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
13,164,573.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
18.8 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
PN |
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
Innovex Co-Invest Fund II, L.P. | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
WC | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
3,073,822.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
4.4 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
PN |
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
Innovex Co-Invest Fund, L.P. | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
WC | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
728,498.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
1 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
PN |
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
Intervale Capital Fund II, L.P. | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
WC | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
628,411.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.9 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
PN |
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
Intervale Capital Fund II-A, L.P. | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
WC | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
311.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
PN |
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
Intervale Capital Fund III, L.P. | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
WC | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
161,707.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.2 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
PN |
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
Amberjack Capital GP II, L.P. | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
AF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
13,164,573.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
18.8 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
PN |
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
Innovex Co-Invest Fund II GP, L.P. | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
AF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
3,073,822.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
4.4 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
PN |
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
Innovex Co-Invest Fund GP, L.P. | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
AF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
728,498.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
1 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
PN |
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
Intervale Capital GP II, L.P. | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
AF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
628,722.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.9 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
PN |
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
Intervale Capital GP III, L.P. | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
AF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
161,707.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.2 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
PN |
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
Amberjack Capital Associates II, LLC | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
AF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
13,164,573.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
18.8 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
OO |
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
Innovex Co-Invest Associates, LLC | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
AF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
3,802,320.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
5.4 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
OO |
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
Interval Capital Associates II, LLC | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
AF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
628,722.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.9 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
OO |
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
Intervale Capital Associates III, LLC | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
AF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
161,707.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
0.2 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
OO |
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
Amberjack Capital Partners, L.P. | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
AF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
17,757,322.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
25.4 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IA, PN |
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
Amberjack Management, LLC | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
AF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
DELAWARE
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
17,757,322.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
25.4 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
HC, OO |
SCHEDULE 13D
|
| CUSIP No. |
| 1 |
Name of reporting person
Jason Turowsky | ||||||||
| 2 | Check the appropriate box if a member of a Group (See Instructions)
(a)
(b) | ||||||||
| 3 | SEC use only | ||||||||
| 4 |
Source of funds (See Instructions)
AF | ||||||||
| 5 |
Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
| ||||||||
| 6 | Citizenship or place of organization
UNITED STATES
| ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 11 | Aggregate amount beneficially owned by each reporting person
17,757,322.00 | ||||||||
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)
| ||||||||
| 13 | Percent of class represented by amount in Row (11)
25.4 % | ||||||||
| 14 | Type of Reporting Person (See Instructions)
IN, HC |
SCHEDULE 13D
|
| Item 1. | Security and Issuer | |
| (a) | Title of Class of Securities:
Common Stock, par value $0.01 per share | |
| (b) | Name of Issuer:
Innovex International, Inc. | |
| (c) | Address of Issuer's Principal Executive Offices:
19120 Kenswick Drive, Humble,
TEXAS
, 77338. | |
Item 1 Comment:
This Amendment No. 3 to Schedule 13D amends and supplements the Schedule 13D filed by the undersigned with the Securities and Exchange Commission (the "SEC") on September 13, 2024, as amended by Amendment No. 1 dated March 6, 2025, and Amendment No. 2 dated February 27, 2026 (the "Schedule 13D"). All capitalized terms contained herein but not otherwise defined shall have the meanings ascribed to such terms in the Schedule 13D. | ||
| Item 4. | Purpose of Transaction | |
Item 4 of the Schedule 13D is hereby amended and supplemented by the addition of the following:
Underwriting Agreement
On August 6, 2026, the Issuer entered into an Underwriting Agreement (the "Underwriting Agreement") with Intervale Capital Fund II, L.P., Intervale Capital Fund II-A, L.P., Intervale Capital Fund III, L.P., Amberjack Capital Fund II, L.P., Innovex Co-Invest Fund, L.P., Innovex Co-Invest Fund II, L.P., (collectively, the "Seller Stockholders") and Barclays Capital Inc., as underwriter (the "Underwriter"), relating to the offer and sale by the Selling Stockholders of 5,000,000 shares of common stock, par value $0.01 per share, of the Issuer (the "Common Stock"), at a price to the Underwriter of $28.71 per share (the "Offering").
Amberjack Capital Fund II, L.P. sold 3,706,801 shares of Common Stock to the Underwriter. Innovex Co-Invest Fund II, L.P. sold 865,508 shares of Common Stock to the Underwriter. Innovex Co-Invest Fund, L.P. sold 205,126 shares of Common Stock to the Underwriter. Intervale Capital Fund II, L.P. sold 176,944 shares of Common Stock to the Underwriter. Intervale Capital Fund II-A, L.P. sold 88 shares of Common Stock to the Underwriter. Intervale Capital Fund III, L.P. sold 45,533 shares of Common Stock to the Underwriter.
The Offering closed on August 10, 2026. The Underwriting Agreement contains customary representations and warranties, agreements and obligations, closing conditions and termination provisions.
The foregoing description of the Underwriting Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Underwriting Agreement, which is incorporated by reference as Exhibit 99.1 and is incorporated herein by reference.
Lock-up Agreement
On August 6, 2026, the Underwriter entered into a lock-up agreement with the Selling Stockholders (the "Lockup Agreement"). Under the Lockup-Agreement, the Selling Stockholders agreed to not and not to cause any affiliates to, during the period beginning on the date of the Lock-up Agreement and ending at the close of business 45 days after the date of the final prospectus relating the Offering, to transfer any Common Stock or any shares underlying such Common Stock without the prior written consent of the Underwriter, subject to certain exceptions.
The foregoing description of the Lock-Up Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Form of Lock-Up Agreement, which is incorporated by reference as Exhibit 99.2 and is incorporated herein by reference. | ||
| Item 5. | Interest in Securities of the Issuer | |
| (a) | Item 5 of the Schedule 13D is hereby amended and restated as follows:
Items 7 through 11 and 13 of each of the cover pages of this Schedule 13D are incorporated herein by reference. Such information is based on 69,935,827 shares of Common Stock of the Issuer outstanding as of August 4, 2026, as reported in the Issuer's Prospectus Supplement filed with the SEC on August 10, 2026.
i. Amberjack Capital Fund II
As of the date hereof, Amberjack Capital Fund II beneficially owns 13,164,573 shares of Common Stock.
Percentage: 18.8%
ii. Innovex Co-Invest Fund II
As of the date hereof, Innovex Co-Invest Fund II beneficially owns 3,073,822 shares of Common Stock.
Percentage: 4.4%
iii. Innovex Co-Invest Fund
As of the date hereof, Innovex Co-Invest Fund beneficially owns 728,498 shares of Common Stock.
Percentage: 1.0%
iv. Intervale Capital Fund II
As of the date hereof, Intervale Capital Fund II beneficially owns 628,411 shares of Common Stock.
Percentage: 0.9%
v. Intervale Capital Fund II-A
As of the date hereof, Intervale Capital Fund II-A beneficially owns 311 shares of Common Stock.
Percentage: 0.0%
vi. Intervale Capital Fund III
As of the date hereof, Intervale Capital Fund III beneficially owns 161,707 shares of Common Stock.
Percentage: 0.2%
vii. Amberjack Capital GP II
Amberjack Capital GP II, as the general partner of Amberjack Capital Fund II, may be deemed the beneficial owner of the 13,164,573 shares of Common Stock owned by Amberjack Capital Fund II.
Percentage: 18.8%
viii. Innovex Co-Invest Fund II GP
Innovex Co-Invest Fund II GP, as the general partner of Innovex Co-Invest Fund II, may be deemed the beneficial owner of the 3,073,822 shares of Common Stock owned by Innovex Co-Invest Fund II.
Percentage: 4.4%
ix. Innovex Co-Invest Fund GP
Innovex Co-Invest Fund GP, as the general partner of Innovex Co-Invest Fund, may be deemed the beneficial owner of the 728,498 shares of Common Stock owned by Innovex Co-Invest Fund.
Percentage: 1.0%
x. Intervale Capital GP II
Intervale Capital GP II, as the general partner of Intervale Capital Fund II and Intervale Capital Fund II-A, may be deemed the beneficial owner of 628,722 shares of Common Stock, comprised of the (i) 628,411 shares of Common Stock owned by Intervale Capital Fund II and (ii) 311 shares of Common Stock owned by Intervale Capital Fund II-A.
Percentage: 0.9%
xi. Intervale Capital GP III
Intervale Capital GP III, as the general partner of Intervale Capital Fund III, may be deemed the beneficial owner of the 161,707 shares of Common Stock owned by Intervale Capital Fund III.
Percentage: 0.2%
xii. Amberjack Capital Associates II
Amberjack Capital Associates II, as the general partner of Amberjack Capital GP II, may be deemed the beneficial owner of the 13,164,573 shares of Common Stock owned by Amberjack Capital Fund II.
Percentage: 18.8%
xiii. Innovex Co-Invest Associates
Innovex Co-Invest Associates, as the general partner of Innovex Co-Invest Fund II GP and Innovex Co-Invest Fund GP, may be deemed the beneficial owner of 3,802,320 shares of Common Stock, comprised of the (i) 3,073,822 shares of Common Stock owned by Innovex Co-Invest Fund II and (ii) 728,498 shares of Common Stock owned by Innovex Co-Invest Fund.
Percentage: 5.4%
xiv. Intervale Capital Associates II
Intervale Capital Associates II, as the general partner of Intervale Capital GP II, may be deemed the beneficial owner of 628,722 shares of Common Stock, comprised of the (i) 628,411 shares of Common Stock owned by Intervale Capital Fund II and (ii) 311 shares of Common Stock owned by Intervale Capital Fund II-A.
Percentage: 0.9%
xv. Intervale Capital Associates III
Intervale Capital Associates III, as the general partner of Intervale Capital GP III, may be deemed the beneficial owner of the 161,707 shares of Common Stock owned by Intervale Capital Fund III.
Percentage: 0.2%
xvi. Amberjack Capital Partners
Amberjack Capital Partners, as the sole member of Amberjack Capital Associates II, Innovex Co-Invest Associates, Intervale Capital Associates II, and Intervale Capital Associates III, may be deemed the beneficial owner of 17,757,322 shares of Common Stock, comprised of the (i) 13,164,573 shares of Common Stock owned by Amberjack Capital Fund II, (ii) 3,073,822 shares of Common Stock owned by Innovex Co-Invest Fund II, (iii) 728,498 shares of Common Stock owned by Innovex Co-Invest Fund, (iv) 628,411 shares of Common Stock owned by Intervale Capital Fund II, (v) 311 shares of Common Stock owned by Intervale Capital Fund II-A, and (vi) 161,707 shares of Common Stock owned by Intervale Capital Fund III.
Percentage: 25.4%
xvii. Amberjack Management
Amberjack Management, as the general partner of Amberjack Capital Partners, may be deemed the beneficial owner of 17,757,322 shares of Common Stock, comprised of the (i) 13,164,573 shares of Common Stock owned by Amberjack Capital Fund II, (ii) 3,073,822 shares of Common Stock owned by Innovex Co-Invest Fund II, (iii) 728,498 shares of Common Stock owned by Innovex Co-Invest Fund, (iv) 628,411 shares of Common Stock owned by Intervale Capital Fund II, (v) 311 shares of Common Stock owned by Intervale Capital Fund II-A, and (vi) 161,707 shares of Common Stock owned by Intervale Capital Fund III.
Percentage: 25.4%
xviii. Jason Turowsky
Jason Turowsky, as managing partner of Amberjack Management, may be deemed the beneficial owner of 17,757,322 shares of Common Stock, comprised of the (i) 13,164,573 shares of Common Stock owned by Amberjack Capital Fund II, (ii) 3,073,822 shares of Common Stock owned by Innovex Co-Invest Fund II, (iii) 728,498 shares of Common Stock owned by Innovex Co-Invest Fund, (iv) 628,411 shares of Common Stock owned by Intervale Capital Fund II, (v) 311 shares of Common Stock owned by Intervale Capital Fund II-A, and (vi) 161,707 shares of Common Stock owned by Intervale Capital Fund III.
Percentage: 25.4% | |
| (b) | i. Amberjack Capital Fund II
1. Sole power to vote or direct vote: 13,164,573
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 13,164,573
4. Shared power to dispose or direct the disposition: 0
ii. Innovex Co-Invest Fund II
1. Sole power to vote or direct vote: 3,073,822
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 3,073,822
4. Shared power to dispose or direct the disposition: 0
iii. Innovex Co-Invest Fund
1. Sole power to vote or direct vote: 728,498
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 728,498
4. Shared power to dispose or direct the disposition: 0
iv. Intervale Capital Fund II
1. Sole power to vote or direct vote: 628,411
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 628,411
4. Shared power to dispose or direct the disposition: 0
v. Intervale Capital Fund II-A
1. Sole power to vote or direct vote: 311
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 311
4. Shared power to dispose or direct the disposition: 0
vi. Intervale Capital Fund III
1. Sole power to vote or direct vote: 161,707
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 161,707
4. Shared power to dispose or direct the disposition: 0
vii. Amberjack Capital GP II
1. Sole power to vote or direct vote: 13,164,573
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 13,164,573
4. Shared power to dispose or direct the disposition: 0
viii. Innovex Co-Invest Fund II GP
1. Sole power to vote or direct vote: 3,073,822
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 3,073,822
4. Shared power to dispose or direct the disposition: 0
ix. Innovex Co-Invest Fund GP
1. Sole power to vote or direct vote: 728,498
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 728,498
4. Shared power to dispose or direct the disposition: 0
x. Intervale Capital GP II
1. Sole power to vote or direct vote: 628,722
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 628,722
4. Shared power to dispose or direct the disposition: 0
xi. Intervale Capital GP III
1. Sole power to vote or direct vote: 161,707
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 161,707
4. Shared power to dispose or direct the disposition: 0
xii. Amberjack Capital Associates II
1. Sole power to vote or direct vote: 13,164,573
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 13,164,573
4. Shared power to dispose or direct the disposition: 0
xiii. Innovex Co-Invest Associates
1. Sole power to vote or direct vote: 3,802,320
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 3,802,320
4. Shared power to dispose or direct the disposition: 0
xiv. Intervale Capital Associates II
1. Sole power to vote or direct vote: 628,722
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 628,722
4. Shared power to dispose or direct the disposition: 0
xv. Intervale Capital Associates III
1. Sole power to vote or direct vote: 161,707
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 161,707
4. Shared power to dispose or direct the disposition: 0
xvi. Amberjack Capital Partners
1. Sole power to vote or direct vote: 17,757,322
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 17,757,322
4. Shared power to dispose or direct the disposition: 0
xvii. Amberjack Management
1. Sole power to vote or direct vote: 17,757,322
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 17,757,322
4. Shared power to dispose or direct the disposition: 0
xviii. Jason Turowsky
1. Sole power to vote or direct vote: 17,757,322
2. Shared power to vote or direct vote: 0
3. Sole power to dispose or direct the disposition: 17,757,322
4. Shared power to dispose or direct the disposition: 0 | |
| (c) | The information in Item 4 is incorporated herein by reference. Except as disclosed in this Schedule 13D, there have been no transactions in the shares of Common Stock effected by the Reporting Persons on behalf of the Funds in the past 60 days. | |
| (d) | Not applicable. | |
| (e) | Not applicable. | |
| Item 7. | Material to be Filed as Exhibits. | |
99.1 Underwriting Agreement, dated as of August 6, 2026, by and among the Issuer, the Seller Stockholders and Barclays Capital Inc. (incorporated by reference to Exhibit 10.1 to the Issuer's Current Report on Form 8-K (File No. 001-13439), filed with the Securities and Exchange Commission on August 10, 2026).
99.2 Form of Lock-up Agreement (incorporated by reference to Exhibit A to Exhibit 10.1 to the Issuer's Current Report on Form 8-K (File No. 001-13439), filed with the Securities and Exchange Commission on August 10, 2026). | ||
| SIGNATURE | |
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|